Biopharma

Illumina board adds activist investor, elevates Scott G...

As it faces uncertainty in the research market at home and abroad, Illumina is m...

Drug discovery pact between Charles River and Valo Heal...

The drug discovery pact between Charles River Laboratories, Valo Health and Flag...

Acrivon stops developing Lilly castoff for ovarian and ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and...

ImmuneOnco axes CD47 bispecific as pipeline prioritizat...

ImmuneOnco Biopharmaceuticals has shown Chinese biotechs are far from immune to ...

Wave's DMD drug remains on track in 48-week data ahead ...

As it gears up to submit an approval application next year, Wave Life Sciences h...

Ascletis slashes funding for former core programs in pi...

Responding to the progress of its obesity pipeline, the Chinese biotech is stepp...

Senate confirms research economist Jay Bhattacharya to ...

The Senate has confirmed President Donald Trump’s pick Jayanta Bhattacharya, M.D...

Supira Medical raises $120M to develop catheter-based v...

The series E round follows the launch of Supira's U.S. feasibility study, which ...

DBS startup Newronika nets European approval for adapti...

Newronika's AlphaDBS system continuously adjusts its output based on real-time b...

Nkarta lays off 3rd of staff, including CFO, to fund au...

Nkarta is laying off a third of its employees, including half of the biotech’s e...

Despite raising $1B over past 5 years, ElevateBio lets ...

Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part ...

Equillium misses primary endpoint, plus 2 key secondari...

Equillium’s phase 3 graft-versus-host disease trial has missed its primary endpo...

Alcon gains upper hand in Aurion power struggle via maj...

Eye care giant Alcon appears to have gained the upper hand in the ongoing power ...

RFK Jr. cuts 4,700 FDA and NIH jobs as HHS eliminates ‘...

The federal government is cutting 3,500 full-time FDA employees and 1,200 NIH wo...

Candel’s lung cancer survival data light path toward pi...

Candel Therapeutics has identified a subpopulation of lung cancer patients livin...

Arbutus jettisons 57% of staff, ceases in-house research

Arbutus Biopharma is stripping its workforce back to just a “core team” needed t...

Senior NIH leader Tara Schwetz put on leave: Stat

Tara Schwetz, Ph.D., a deputy director at the National Institutes of Health and ...

Langer spin-out Lyndra Therapeutics begins winding down...

Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at...

FDA’s novel medical device clearances slow to a crawl

According to the FDA’s public database, since the start of this year the agency ...

Abbott secures European approval for Volt pulsed field ...

Abbott is joining the worldwide race to make pulsed field ablation the standard ...

STAT+: HHS layoffs rile Democrats, but Republicans say ...

Democrats predict lawsuits, disrupted care after layoffs. Republicans say cuts w...

STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to ...

Sen. Ron Wyden and other Democrats claim Pfizer used a "colossal" scheme to avoi...

STAT+: RFK Jr. brings FDA under tighter control with HH...

WASHINGTON — Around 3,500 employees are on the chopping block at the Food and Dr...

RFK Jr. plans to slash HHS workforce by 25% in massive ...

The Health and Human Services Department is set to slash 10,000 jobs and streaml...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.